AI Tools: Dos and Don’ts for Healthcare Agencies
There’s been plenty of cross-industry discussion about what to do (and what not to do) with generative AI tools, such as ChatGPT. This technology can be incredible for generating content, delivering quick answers to questions that a search engine may not return as efficiently, and providing “smarter” responses to more abstract or complex inquiries. Based on our own experience, we’ve compiled a list of dos and don’ts to help marketing and PR pros understand different use cases, and how...
The B2B Healthcare Month in Review: April 2023
The Activate Health team is back with another roundup of the most impactful healthcare news headlines to save you time. Regulatory news from quarter two includes the end of the COVID-19 national emergency and the start of Medicaid redeterminations. And as 2023 healthcare costs continue to rise, numerous researchers point out the impacts of more healthcare spending for people with employer-sponsored coverage, plus increases in ACA premiums. REGULATORY NEWS Biden signs measure ending...
The B2B Healthcare Month in Review: March 2023
As March rounds out the first quarter of 2023, the Activate Health team has pulled together a collection of top healthcare stories for busy healthcare marketing and PR professionals. Multiple regulatory updates hit the wire this month, from CMS negotiating drug prices to the DEA placing restrictions on drugs prescribed via telehealth appointments. New research also reveals important insights on prior authorizations and the future of employee benefits. M&A NEWS Elevance agrees to...
The B2B Healthcare Month in Review: February 2023
This month has come and gone and we’ve complied a list of the top headlines for busy healthcare marketing and PR professionals. Progress is being made on the regulatory front as CMS aims to align it’s standards across all of its 20+ programs, and the president calls for a cap on insulin for all Americans. CVS is also back in the headlines with a $10.6B deal with Oak Street Health. And as spring is quickly approaching, the HHS is preparing states for the end of the COVID-19 public health...
The B2B Healthcare Month in Review: January 2023
To help ease the stress of the new year, the Activate Health team has pulled together a list of need-to-know stories for busy healthcare marketing and PR professionals. The start of 2023 brings new initiatives and policies, including a $35 cap on the monthly cost of insulin for Medicare beneficiaries and a $1.7 trillion spending package. Enrollment in both Medicare Advantage and ACA plans are hitting all-time highs. And on the COVID-19 front, the country’s national public health emergencies...
The B2B Healthcare Month in Review: December 2022
As 2022 comes to a close, we’ve compiled the top healthcare headlines from December to help busy healthcare marketing and PR professionals stay up to date. Numerous regulatory stories make up this month’s headlines including The Centers for Medicare & Medicaid Services’ (CMS) bid to implement electronic prior authorization systems and the reduction of the number of plans insurers can offer through the ACA Marketplace. Also, as we round out the year, surveys and studies show that people...